Free Trial

Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume

→ Write this ticker symbol down… (From StocksToTrade) (Ad)
Free ALPMY Stock Alerts
$9.90
-0.09 (-0.90%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest

Astellas Pharma Short Interest Data

Current Short Interest
74,100 shares
Previous Short Interest
83,900 shares
Change Vs. Previous Month
-11.68%
Dollar Volume Sold Short
$726,180.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
1,809,660,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
524,696 shares
Average Trading Volume
297,921 shares
Today's Volume Vs. Average
176%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Astellas Pharma ?

Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ALPMY Short Interest Over Time

ALPMY Days to Cover Over Time

ALPMY Percentage of Float Shorted Over Time

Astellas Pharma Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80
4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55
4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27
3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75
3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83
2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93
2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05
1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08
12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90
12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36
11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16
11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65
10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69
10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04
9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85
9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91
8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14
8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13
7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63
7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40
6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87
6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12
5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77
5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03
4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02
4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81
3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20
3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77
2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00
2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37
1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68
1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62
12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16
12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57
11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46
11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07
10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86
10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33
9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33
9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77
A once-in-a-century investment opportunity (Ad)

It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.

To get its name and ticker symbol for free - just click here.
8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30
7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57
7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82
6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56
6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98
5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91
5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15
4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17
4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45
3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58
3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66
2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68
2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27
1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15
1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51
12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27
12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91
11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56
11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37
10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88
10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55
9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52
9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00
8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78
8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23
7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92
7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41
6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38
6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53
5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22
5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26
4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95
4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08
3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64
3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65
2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52
2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99
1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38
1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91
12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40
12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59
11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59
11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52
10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91
10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16
9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91
9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24
8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67
8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36
7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70
A once-in-a-century investment opportunity (Ad)

It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.

To get its name and ticker symbol for free - just click here.
7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33
6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66
6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47
5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84
5/15/20204,800 shares $76,800.00 -66.0%N/A0.1 $16.00
4/30/202014,100 shares $230,535.00 +65.9%N/A0.1 $16.35
4/15/20208,500 shares $138,805.00 +7.6%N/A0.1 $16.33
3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35
3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52
2/28/202032,400 shares $427,032.00 -20.6%N/A0.4 $13.18
2/14/202040,800 shares $641,376.00 +164.9%N/A0.5 $15.72
1/31/202015,400 shares $249,172.00 -32.5%N/A0.3 $16.18
1/15/202022,800 shares $418,608.00 -30.3%N/A0.3 $18.36
12/31/201932,700 shares $569,307.00 +1,621.1%N/A0.5 $17.41

ALPMY Short Interest - Frequently Asked Questions

What is Astellas Pharma's current short interest?

Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 74,100 shares of ALPMY short. Learn More on Astellas Pharma's current short interest.

Is Astellas Pharma's short interest increasing or decreasing?

Astellas Pharma saw a decrease in short interest in May. As of May 15th, there was short interest totaling 74,100 shares, a decrease of 11.7% from the previous total of 83,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Astellas Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Astellas Pharma: Teva Pharmaceutical Industries Limited (1.16%), BeiGene, Ltd. (1.75%), Alnylam Pharmaceuticals, Inc. (2.01%), Genmab A/S (0.45%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Sarepta Therapeutics, Inc. (6.94%), Merck KGaA (0.37%), Dr. Reddy's Laboratories Limited (0.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Astellas Pharma stock?

Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Astellas Pharma?

A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further.

How often is Astellas Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (OTCMKTS:ALPMY) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
You won't believe what Citigroup just did to it's depositors
American Alternative
4 Cryptos BETTER than Bitcoin
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits
A once-in-a-century investment opportunity
Stansberry Research
Write this ticker symbol down…
StocksToTrade
Bill Clinton Backing Biden Replacement???
The Freeport Society
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace